BioCentury
ARTICLE | Company News

Alfama, hemoCORM Ltd. deal

September 15, 2008 7:00 AM UTC

The two developers of carbon monoxide (CO)-releasing therapeutics will merge. The combined company, which will retain Alfama's name, has preclinical CO programs to treat acute liver failure and multip...